The Brussels holding company Groep Brussel Lambert (GBL) is investing again in the health sector. This time it takes a majority stake in Sanoptis, a group active in ophthalmology (ophthalmology) in Germany and Switzerland. The Bel20 holding has announced this.
Founded in 2018, Sanoptis offers ophthalmic services ranging from consultations to surgeries in more than 250 practices in Germany and Switzerland. It recorded a turnover of around 300 million euros in 2021.
GBL is contributing up to 750 million in equity for the acquisition of the majority stake of the investment group Telemos Capital in Sanoptis. Together with the management team, GBL aims to build on Sanoptis’ impressive growth story, both in the markets in which it is already active and through further internationalization in attractive new European markets. The transaction is expected to close in the second quarter.
On Tuesday, GBL announced the acquisition of Affidea, a European leader in medical diagnostics.
The health sector is one of the four investment pillars of the Bel20 holding, alongside consumer experience, digitization & technology, and sustainability.
Free unlimited access to Showbytes? Which can!
Log in or create an account and never miss a thing from the stars.